authors
- Downen, Sarah S
- Farag, Hussein M
- Davies, Abby
- Okeke, Chijioke M
- Ben-Umeh, Kenechukwu C
- Ismaeel Yunusa, PharmD, PhD
- Eguale, Tewodros
Cost-Effectiveness of Pregabalin, Duloxetine, and Milnacipran vs Amitriptyline for Moderate to Severe Fibromyalgia.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- February 2, 2026
published in
- JAMA network open Journal
has subject area
- Adolescent
- Adult
- Amitriptyline
- Analgesics
- Analgesics, Non-Narcotic
- Cohort Studies
- Computer Simulation
- Cost Savings
- Cost-Benefit Analysis
- Cost-Effectiveness Analysis
- Dose-Response Relationship, Drug
- Drug Costs
- Duloxetine Hydrochloride
- Female
- Fibromyalgia
- Humans
- Male
- Markov Chains
- Middle Aged
- Milnacipran
- Pregabalin
- Quality of Life
- Quality-Adjusted Life Years
- Severity of Illness Index
- Young Adult